Market Share of Global Hemato Oncology Testing Industry
The hemato-oncology testing market is fragmented and competitive in nature. The companies have been following various strategies such as acquisitions, partnerships, investments in research activities, and new product launches to sustain themselves among the competitors in the global market. The market consists of several major players, and a few of the major players are currently dominating the market, which include F. Hoffmann-La Roche Ltd, Abbott, QIAGEN, Thermo Fisher Scientific Inc., and Illumina Inc.
Hemato Oncology Testing Market Leaders
Abbott
QIAGEN
F. Hoffmann-La Roche Ltd
Illumina Inc.
Thermo Fisher Scientific Inc.
*Disclaimer: Major Players sorted in no particular order
